Acadia received two patent rulings that strengthen Nuplazid’s patent position an...
Experts discussed the potential impacts of climate change on the pharma supply c...
Novo Nordisk will pay $92.5m in one-time cash payment to Alkermes, and the deal ...
A Phase II clinical trial treating 160 acute kidney injury patients with MTX652 ...
In this article, we’ll explore the patient communication risks that now confront...
When is a diagnostic test for a rare disease worth taking?
Sobering centers offer a safe place to recover from intoxication. Every communit...
For a 7-year-old girl, a gene therapy for beta thalassemia offered freedom. The ...
Doctors' assumptions about patients with disabilities can undermine cancer care ...
Novartis unveiled early animal data suggesting that they might have a promising ...
Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit allegin...
The CEO of Maze Therapeutics said he learned Sanofi would end its partnership wi...
A new type of targeted therapy enabled a leukemia patient to "see my dog, hang o...
Researchers reported advances in bone marrow transplants, a less expensive way t...
Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ m...
New federal rules will force software vendors to disclose how AI tools used in h...
